These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8749868)

  • 21. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.
    Zijlstra F; de Boer MJ; Beukema WP; Liem AL; Reiffers S; Huysmans D; Hoorntje JC; Suryapranata H; Simoons ML
    Eur Heart J; 1996 Mar; 17(3):382-7. PubMed ID: 8737211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
    Alexander JH; Granger CB; Sadowski Z; Aylward PE; White HD; Thompson TD; Califf RM; Topol EJ
    Am Heart J; 1999 May; 137(5):799-805. PubMed ID: 10220627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous intravenous infusion of magnesium sulfate after acute myocardial infarction.
    Abraham AS; Balkin J; Rosenmann D; Eylath U; Zion MM
    Magnes Trace Elem; 1990; 9(3):137-42. PubMed ID: 2248694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators.
    Tebbe U; Michels R; Adgey J; Boland J; Caspi A; Charbonnier B; Windeler J; Barth H; Groves R; Hopkins GR; Fennell W; Betriu A; Ruda M; Mlczoch J
    J Am Coll Cardiol; 1998 Mar; 31(3):487-93. PubMed ID: 9502624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.
    Smith LF; Heagerty AM; Bing RF; Barnett DB
    Int J Cardiol; 1986 Aug; 12(2):175-83. PubMed ID: 2427458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilot Study Investigators.
    Flather M; Pipilis A; Collins R; Budaj A; Hargreaves A; Kolettis T; Jacob A; Millane T; Fitzgerald L; Cedro K
    Eur Heart J; 1994 May; 15(5):608-19. PubMed ID: 8055999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy.
    Krljanac G; Vasiljević Z; Radovanović M; Stanković G; Milić N; Stefanović B; Kostić J; Mitrović P; Radovanović N; Dragović M; Marinković J; Karadzić A
    Am J Cardiol; 2005 Oct; 96(8):1053-8. PubMed ID: 16214437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction.
    Parikka H; Toivonen L; Naukkarinen V; Tierala I; Pohjola-Sintonen S; Heikkilä J; Nieminen MS
    Eur Heart J; 1999 Jan; 20(2):111-20. PubMed ID: 10099907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atenolol i.v. in the acute phase of AMI: the indications, contraindications and interactions with thrombolytic drugs in the GISSI-2 study. The GISSI-2 Researchers. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Mafrici A; Mauri F; Maggioni AP; Franzosi MG; Santoro L; De Vita C
    G Ital Cardiol; 1995 Mar; 25(3):353-64. PubMed ID: 7642042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era.
    Hohnloser SH; Klingenheben T; Zabel M; Schöpperl M; Mauss O
    J Am Coll Cardiol; 1999 Jun; 33(7):1895-902. PubMed ID: 10362190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction.
    Ghaffari S; Kazemi B; Toluey M; Sepehrvand N
    Cardiovasc Ther; 2013 Aug; 31(4):e34-9. PubMed ID: 23061531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction.
    Roffe C; Fletcher S; Woods KL
    Br Heart J; 1994 Feb; 71(2):141-5. PubMed ID: 8130021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
    Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ
    J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parenteral magnesium sulfate versus amiodarone in the therapy of atrial tachyarrhythmias: a prospective, randomized study.
    Moran JL; Gallagher J; Peake SL; Cunningham DN; Salagaras M; Leppard P
    Crit Care Med; 1995 Nov; 23(11):1816-24. PubMed ID: 7587256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial of magnesium sulfate, in addition to usual care, for rate control in atrial fibrillation.
    Davey MJ; Teubner D
    Ann Emerg Med; 2005 Apr; 45(4):347-53. PubMed ID: 15795711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
    Van de Werf F; Janssens L; Brzostek T; Mortelmans L; Wackers FJ; Willems GM; Heidbüchel H; Lesaffre E; Scheys I; Collen D
    J Am Coll Cardiol; 1993 Aug; 22(2):407-16. PubMed ID: 8335810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction.
    Ribeiro EE; Silva LA; Carneiro R; D'Oliveira LG; Gasquez A; Amino JG; Tavares JR; Petrizzo A; Torossian S; Duprat Filho R
    J Am Coll Cardiol; 1993 Aug; 22(2):376-80. PubMed ID: 8335807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved left ventricular function in myocardial infarction following intravenous thrombolytic therapy with acylated plasminogen activator.
    Ovsyshcher I; Silber H; Hausman MI; Margolis G; Gueron M
    Angiology; 1990 Feb; 41(2):133-8. PubMed ID: 2407157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.